Proprioception on Balance and Gait in Hemiparetics

Sponsor

Istanbul Aydın University (Other)

Overall Status

Active, not recruiting

CT.gov ID

NCT05027841

Collaborator

(none)

Enrollment

Location

Anticipated Duration (Months)

2.3

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The loss of sensorial feedback causes gait impairment in hemiparesis. The studies show that proprioceptive impairment of knee is related to falling in these patients. The aim of this study is to investigate the effects of proprioception on balance and gait functions in hemiparetic individuals.

Condition or Disease	Intervention/Treatment	Phase
Hemiparesis Proprioceptive Disorders Gait, Hemiplegic	Other: Proprioseption in hemiparetics

Study Design

Study Type:

Observational

Anticipated Enrollment :

28 participants

Observational Model:

Case-Control

Time Perspective:

Cross-Sectional

Official Title:

Investigation of The Effect of Proprioception on Balance and Gait Functions in Hemiparetic Individuals

Actual Study Start Date :

Aug 13, 2021

Anticipated Primary Completion Date :

Jul 13, 2022

Anticipated Study Completion Date :

Aug 13, 2022

Outcome Measures

Primary Outcome Measures

Sensorial Assessment-1 [2 minutes]
Semmes-Weinstein Monoflament
Sensorial Assessment-2 [2 minutes]
Position test for lower extremity
Sensorial Assessment-3 [2 minutes]
Kinestesia (Electrogoniometer)
Balance assessment [30 second]
Static balance via SportKAT-550
Gait parameters [1 minute]
BTS G-Walk Spatiotemporal gait parameters

Eligibility Criteria

Criteria

Ages Eligible for Study:

20 Years to 65 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Between the ages of 20-65 and discharged from the hospital,
Diagnosed with hemiparesis at least 4 weeks ago,
First time and unilateral hemiparesis,
Modified Rankin Score ≤ 3,
Hodkinson Mental Test ≥ 6,
Individuals who agree to receive treatment will be included in the study.

Exclusion Criteria:

Having vision and hearing problems,
Having other accompanying neurological, psychiatric and/or orthopedic problems other than hemiparesis,
Medically unstable,
Diseases that will affect the lower extremity sense,
Individuals with open wounds, circulation problems, and skin lesions in the area to be treated will be excluded from the study.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Istanbul Aydın University	Istanbul		Turkey

Sponsors and Collaborators

Istanbul Aydın University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Seref Duhan Altug, PT, Istanbul Aydın University

ClinicalTrials.gov Identifier:

NCT05027841

Other Study ID Numbers:

E-60116787-020-5302

First Posted:

Aug 30, 2021

Last Update Posted:

Aug 30, 2021

Last Verified:

Aug 1, 2021

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Additional relevant MeSH terms:

Paresis

Gait Disorders, Neurologic

Somatosensory Disorders

Study Results

No Results Posted as of Aug 30, 2021